You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR TOPAMAX SPRINKLE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TOPAMAX SPRINKLE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00648934 ↗	Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Completed	Mylan Pharmaceuticals	Phase 1	2005-11-01	The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsules to Ortho-McNeil's Topamax® Sprinkle 25 mg capsules following a single, oral 25 mg (1 x 25 mg) dose administered under fed conditions.
NCT00649467 ↗	Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Completed	Mylan Pharmaceuticals	Phase 1	2005-11-01	The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsule to Ortho-McNeil's Topamax® Sprinkle 25 mg capsule following a single, oral 25 mg (1 x 25 mg) dose sprinkled on one teaspoon of applesauce under fasting conditions.
NCT00649740 ↗	Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg	Completed	Mylan Pharmaceuticals	Phase 1	2005-11-01	The objective of this study was to investigate the bioequivalence of Mylan's topiramate sprinkle 25 mg capsule to Ortho-McNeil's Topamax® Sprinkle 25 mg capsule following a single, oral 25 mg (1 x 25 mg) dose administered under fasting conditions.
NCT00905164 ↗	Topiramate 25 mg Capsules Under Fasting Conditions	Completed	Teva Pharmaceuticals USA	Phase 1	2002-06-01	The objective of this study was to compare the rate and extent of absorption of topiramate 25 mg capsules (test) versus Topamax® (reference) administered as 2 x 25 mg capsules under fasting conditions.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TOPAMAX SPRINKLE

Condition Name

Chart
Table

Condition Name for TOPAMAX SPRINKLE
Intervention	Trials
Healthy	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TOPAMAX SPRINKLE
Intervention	Trials
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TOPAMAX SPRINKLE

Trials by Country

Map
Table

Trials by Country for TOPAMAX SPRINKLE
Location	Trials
United States	3
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TOPAMAX SPRINKLE
Location	Trials
West Virginia	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TOPAMAX SPRINKLE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TOPAMAX SPRINKLE
Clinical Trial Phase	Trials
Phase 1	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TOPAMAX SPRINKLE
Clinical Trial Phase	Trials
Completed	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TOPAMAX SPRINKLE

Sponsor Name

Chart
Table

Sponsor Name for TOPAMAX SPRINKLE
Sponsor	Trials
Mylan Pharmaceuticals	3
Teva Pharmaceuticals USA	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TOPAMAX SPRINKLE
Sponsor	Trials
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.